Literature DB >> 35466689

Contributions of afferent and sympathetic renal nerves to cystogenesis and arterial pressure regulation in a preclinical model of autosomal recessive polycystic kidney disease.

Madeline M Gauthier1, Melissa R Dennis1, Mark N Morales1, Heddwen L Brooks1, Christopher T Banek1,2.   

Abstract

Polycystic kidney disease (PKD) is the most common inheritable cause of kidney failure, and the underlying mechanisms remain incompletely uncovered. Renal nerves contribute to hypertension and chronic kidney disease-frequent complications of PKD. There is limited evidence that renal nerves may contribute to cardiorenal dysfunction in PKD and no investigations of the role of sympathetic versus afferent nerves in PKD. Afferent renal nerve activity (ARNA) is elevated in models of renal disease and fibrosis. However, it remains unknown if this is true in PKD. We tested the hypothesis that ARNA is elevated in a preclinical model of autosomal recessive PKD and that targeted renal nerve ablation would attenuate cystogenesis and cardiorenal dysfunction. We tested this by performing total renal denervation (T-RDNx) or afferent renal denervation (A-RDNx) denervation in 4-wk-old male and female PCK rats and then quantified renal and cardiovascular responses 6 wk following treatment. Cystogenesis was attenuated with A-RDNx and T-RDNx versus sham controls, highlighting a crucial role for renal afferent nerves in cystogenesis. In contrast, blood pressure was improved with T-RDNx but not A-RDNx. Importantly, treatments produced similar results in both males and females. Direct renal afferent nerve recordings revealed that ARNA was twofold greater in PCK rats versus noncystic controls and was directly correlated with cystic severity. To our knowledge, we are the first to demonstrate that PCK rats have greater ARNA than noncystic, age-matched controls. The findings of this study support a novel and crucial role for renal afferent innervation in cystogenesis in the PCK rat.NEW & NOTEWORTHY This is the first study to dissect the contributions of renal sympathetic and afferent innervation in the PCK rat, a preclinical model of autosomal recessive polycystic kidney disease. We demonstrated that resting afferent renal nerve activity is greater in the PCK rat than noncystic controls and that basal afferent renal nerve activity is directly correlated with the extent of renal cystogenesis.

Entities:  

Keywords:  afferent nerve activity; polycystic kidney disease; renal afferent nerves; renal denervation; sex differences

Mesh:

Year:  2022        PMID: 35466689      PMCID: PMC9159540          DOI: 10.1152/ajprenal.00009.2022

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  45 in total

1.  Vasopressin antagonists in polycystic kidney disease.

Authors:  Vicente E Torres
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

2.  Kidney transplant for autosomal dominant polycystic kidney disease: the superiority of concurrent bilateral nephrectomy.

Authors:  Wen-Li Song; Jian-Ming Zheng; Chun-Bai Mo; Zhi-Ping Wang; Ying-Xin Fu; Gang Feng; Zhong-Yang Shen
Journal:  Urol Int       Date:  2011-06-11       Impact factor: 2.089

3.  Role of spinal V1a receptors in regulation of arterial pressure during acute and chronic osmotic stress.

Authors:  Britta Veitenheimer; John W Osborn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-01       Impact factor: 3.619

4.  Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approach.

Authors:  Frédéric Jacob; Leah A Clark; Pilar Ariza Guzman; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-06-03       Impact factor: 4.733

Review 5.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

Review 6.  Role of renal sensory nerves in physiological and pathophysiological conditions.

Authors:  Ulla C Kopp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-19       Impact factor: 3.619

7.  Disease stage characterization of hepatorenal fibrocystic pathology in the PCK rat model of ARPKD.

Authors:  Stephen B Mason; Yun Liang; Rachel M Sinders; Caroline A Miller; Tracy Eggleston-Gulyas; Robin Crisler-Roberts; Peter C Harris; Vincent H Gattone
Journal:  Anat Rec (Hoboken)       Date:  2010-08       Impact factor: 2.064

8.  Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.

Authors:  Vincent H Gattone; Tibério M Siqueira; Charles R Powell; Chad M Trambaugh; James E Lingeman; Arieh L Shalhav
Journal:  Exp Biol Med (Maywood)       Date:  2008-05-14

9.  Chronic kidney pain in autosomal dominant polycystic kidney disease: a case report of successful treatment by catheter-based renal denervation.

Authors:  Niek F Casteleijn; Rosa L de Jager; M Peer Neeleman; Peter J Blankestijn; Ron T Gansevoort
Journal:  Am J Kidney Dis       Date:  2014-02-08       Impact factor: 8.860

10.  β3 adrenergic receptor as potential therapeutic target in ADPKD.

Authors:  Giorgia Schena; Monica Carmosino; Samantha Chiurlia; Laura Onuchic; Mauro Mastropasqua; Eugenio Maiorano; Francesco P Schena; Michael J Caplan
Journal:  Physiol Rep       Date:  2021-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.